Target intelligence / Profile preview

Polyglutamine-binding protein 1 (PQBP1)

Target
PQBP1
Molecular classification
Other (nuclear polyglutamine-binding protein), Intrinsically disordered protein, Spliceosomal-associated protein, RNA-binding protein
01

Overview

Polyglutamine-binding protein 1 (PQBP1) is a nuclear protein encoded by the *PQBP1* gene located on the X chromosome. It is characterized by a WW domain—mediating protein-protein interactions—and a highly degenerate, intrinsically disordered C-terminal domain. PQBP1’s primary molecular functions involve regulation of pre-mRNA splicing and gene transcription through interactions with RNA polymerase II and spliceosome components. PQBP1 also participates in the formation of RNA granules within neurons, facilitating RNA storage and regulated translation. Genetically, it is notable for its involvement in X-linked intellectual disability syndromes such as Renpenning syndrome, with pathogenic mutations typically leading to loss of function, and thus impaired neuronal RNA processing and development. PQBP1 also interacts with— and is affected by—pathogenic proteins seen in neurodegenerative diseases (such as mutant Ataxin-1, Huntingtin, and tau), further linking RNA dysregulation and protein misfolding to disease pathogenesis. Recent studies implicate PQBP1 as an adaptor protein mediating innate immune detection of retroviruses (HIV-1) and pathologic tau aggregates in microglia, where PQBP1 can act as an intracellular pathogen and damage sensor. There are currently no drugs developed to directly target PQBP1, nor does it fall into categories such as receptor, enzyme, or transporter.

Other names
Polyglutamine tract-binding protein 1NPW38JM26PQBP-1Npw3838 kDa nuclear protein containing a WW domainMRX2MRX55MRXS3MRXS8RENS1SHS
02

Biological functions

mRNA splicingGene transcription regulationRNA processing and transportProtein translation elongationIntracellular pathogen sensing (innate immune response)
03

Disease associations

Neurodegenerative disease (e.g., Huntington’s disease, Alzheimer’s disease, tauopathy)Intellectual disability (X-linked ID, including Renpenning syndrome, Golabi-Ito-Hall syndrome)Other (potential implications in viral infection through innate immune sensing)
04

Safety considerations

Aberrant PQBP1 function is associated with impaired neuronal development and neurodegenerationNot a therapeutic target, so no drug-specific safety profile is established
05

Biomarkers

PQBP1 mutation/deletion (diagnostic in Renpenning syndrome and related X-linked intellectual disabilities)PQBP1 nuclear/cytoplasmic levels (potential relevance in neurodegenerative disease biology)

Beyond the preview

Go deeper on Polyglutamine-binding protein 1 (PQBP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Polyglutamine-binding protein 1 (PQBP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call